Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00113048
Status:
TERMINATED
Last Update Posted:
2014-02-05
First Post:
2005-06-03
Brief Title:
Subcutaneously Administered CAMPATH in CD52 Expressing Hematologic Malignancies
Sponsor:
Genzyme a Sanofi Company
Organization:
Sanofi
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-12
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2005-09
Completion Date Type:
None
First Submit Date:
2005-06-03
First Submit QC Date:
June 3 2005
Study First Post Date:
2005-06-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-02-04
Last Update Post Date:
2014-02-05
Last Update Post Date Type:
ESTIMATED